Quantum Cyber N.V. Current Liabilities
Quantum Cyber N.V. (QUCY) had Current Liabilities of $3.00 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Liabilities, Current $3.00M.
- 2026-03-31: Liabilities, Current $3.13M.
- 2025-12-31: Liabilities, Current $4.69M; Liabilities, Current as first filed $3.69M.
- 2024-12-31: Liabilities, Current $6.18M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.00M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.13M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $4.69M 10-Q · filed 2026-08-14 | $3.69M 10-K · filed 2026-03-31 |
| 2024-12-31 | $6.18M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |